Chemoinformaics analysis of 1-(2-Furyl)propane-1,2-dione
Molecular Weight | 138.122 | nRot | 2 |
Heavy Atom Molecular Weight | 132.074 | nRig | 7 |
Exact Molecular Weight | 138.032 | nRing | 1 |
Solubility: LogS | -1.194 | nHRing | 1 |
Solubility: LogP | 0.634 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
No. of Oxygen atom | 3 | No. of Arom Bond | 5 |
nHA | 3 | APOL | 18.0968 |
nHD | 0 | BPOL | 9.49124 |
QED | 0.453 |
Synth | 2.303 |
Natural Product Likeliness | -0.633 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.038 |
Pgp-sub | 0.001 |
HIA | 0.006 |
CACO-2 | -4.388 |
MDCK | 0.0000228 |
BBB | 0.141 |
PPB | 0.853515 |
VDSS | 0.76 |
FU | 0.232413 |
CYP1A2-inh | 0.928 |
CYP1A2-sub | 0.556 |
CYP2c19-inh | 0.314 |
CYP2c19-sub | 0.112 |
CYP2c9-inh | 0.111 |
CYP2c9-sub | 0.215 |
CYP2d6-inh | 0.009 |
CYP2d6-sub | 0.205 |
CYP3a4-inh | 0.008 |
CYP3a4-sub | 0.217 |
CL | 6.235 |
T12 | 0.737 |
hERG | 0.092 |
Ames | 0.526 |
ROA | 0.901 |
SkinSen | 0.194 |
Carcinogencity | 0.849 |
EI | 0.994 |
Respiratory | 0.908 |
NR-Aromatase | 0.009 |
Antiviral | No |
Prediction | 0.897672 |